Confirmed: Mast Cell Drug Curbs ALS Mortality

(MedPage Today) -- BOSTON -- When phase II/III trial results were published in 2019 for a novel approach to treating amyotrophic lateral sclerosis (ALS), the 48-week data left an important question unanswered: did the treatment extend survival...

Source: MedPage Today Neurology - April 26, 2023 Category: Neurology Source Type: news